Unlike most congeners from the subfamily of neolamellarins isolated from the same source, 7-hydroxyneolamellarin A (25) effectively inhibited hypoxia-induced HIF-1 activation in a T47D human breast tumor cell-based reporter assay, suppressing also the activation of VEGF [140]. This evidence concerns the gene HIF1A and breast neoplasm.